Nanjing Vazyme Biotech Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 4/6
Nanjing Vazyme Biotech has a total shareholder equity of CN¥3.9B and total debt of CN¥500.9M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are CN¥4.9B and CN¥959.4M respectively.
Wichtige Informationen
12.7%
Verhältnis von Schulden zu Eigenkapital
CN¥500.92m
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | CN¥2.47b |
| Eigenkapital | CN¥3.94b |
| Gesamtverbindlichkeiten | CN¥959.43m |
| Gesamtvermögen | CN¥4.90b |
Jüngste Berichte zur Finanzlage
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 688105's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥731.2M).
Langfristige Verbindlichkeiten: 688105's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥228.2M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 688105 has more cash than its total debt.
Schulden abbauen: 688105's debt to equity ratio has reduced from 18% to 12.7% over the past 5 years.
Schuldendeckung: 688105's debt is not well covered by operating cash flow (14.3%).
Zinsdeckung: Insufficient data to determine if 688105's interest payments on its debt are well covered by EBIT.